Sun Pharma Ends Effort to Buy Rest of Taro Pharmaceutical

Sun Pharmaceutical Industries Ltd. ended an effort to buy the remaining stock of Taro Pharmaceutical Industries Ltd. for about $685 million after Taro shareholders held out for a higher price.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.